Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Typharm is a UK-based pharmaceutical company specializing in the development and commercialization of products for dermatology, gastrointestinal health, and nutritional supplements. The company is well-known for its range of topical corticosteroid treatments, including the Haelan product line, and its innovative medicated tape for localized skin conditions. Typharm focuses on providing effective solutions for common conditions such as psoriasis, eczema, and haemorrhoids, while also offering specialized nutritional products like high-dose Vitamin D. With a long-standing presence in the British healthcare market, the company continues to manage a portfolio of established brands and niche therapeutic products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Typharm Developments.